Is Your Paper Ready for Nature Reviews Microbiology? The Invitation-Only Reality

Nature Reviews Microbiology editors track the microbiology and infectious disease literature closely and identify review candidates based on three primary signals: a consistent record of publications in high-impact microbiology journals in a defined area; a citation pattern showing that the researcher's work is being used by others to frame their questions about pathogen biology, host-microbe interactions, or microbial ecology; and evidence of broad enough expertise to synthesize a topic rather than primarily promote the author's own findings.

According to the journal's editorial model, the invitation process covers both academic researchers and, in areas where clinical or public health significance is central, infectious disease clinicians and public health scientists whose translational experience adds authority to the synthesis. Researchers who have published in Nature Microbiology, Cell Host and Microbe, PLOS Pathogens, mBio, or equivalent journals with sustained frequency in a defined area are the realistic invitation candidates.

There is no structured proposal form. Researchers who want to approach the journal proactively should email the editorial office with a brief proposal covering the topic, the author team's qualifications, and why this review is needed now rather than being duplicative of recent reviews in the area.

In our pre-submission review work with manuscripts targeting high-impact microbiology journals, five patterns generate the most consistent desk rejections worth knowing before submission.

Pathogen papers showing virulence phenotypes without resolving the mechanism.

According to Nature Microbiology's author guidelines, the journal expects manuscripts to identify the molecular mechanisms underlying microbiological observations rather than to document that a gene or factor contributes to a phenotype without mechanistic explanation. We see this pattern in manuscripts we review more frequently than any other microbiology-specific failure. Papers that identify a virulence gene using transposon mutagenesis or CRISPR screening and show that deletion reduces virulence without explaining the molecular mechanism linking the gene's function to the virulence outcome face desk rejection before external review. In our experience, roughly 45% of pathogen biology manuscripts we review have a mechanism gap where the phenotype is documented but the molecular logic is not resolved.

Host-microbe papers that treat host biology as readout rather than mechanism.

Per Cell Host and Microbe's author guidelines, the journal expects that host-microbe interaction papers demonstrate mechanistic understanding of what the pathogen does to host cell biology and how the host responds, not only that the pathogen affects host cell viability or function. We see this in roughly 40% of host-microbe manuscripts we review, where a pathogen effector is shown to be translocated and to affect a cellular phenotype without identifying the host target or the molecular mechanism of the interaction. Editors consistently reject papers where the host biology is treated as a readout rather than as a mechanistic participant in the interaction being studied.

Microbiome papers with correlation data but no mechanistic intervention.

Editors consistently flag manuscripts where microbiome composition differences between conditions are reported as the primary finding without any mechanistic evidence connecting the microbiome change to the biological outcome described. In practice, desk rejection tends to occur within the first read for papers that report a microbiome association using 16S sequencing or shotgun metagenomics without any experiment demonstrating that the microbial community change drives or is required for the associated phenotype. In our experience, roughly 35% of microbiome manuscripts we evaluate present correlation findings without a mechanistic intervention that supports causality.

Antimicrobial papers lacking in vivo pharmacodynamic and efficacy data.

mBio and Cell Host and Microbe editors look for in vivo efficacy data supporting antimicrobial claims when papers report new compounds or strategies targeting bacterial or fungal pathogens. Papers where a new antimicrobial agent shows potent in vitro activity without any animal infection model data face significant revision requests or desk rejection at journals that expect translational relevance. According to mBio's author guidelines, papers reporting new antimicrobial activities are expected to include mechanistic data on the mode of action as well as initial in vivo evidence of efficacy in a relevant infection model.

Primary research that is really a replication study in a new organism.

In our analysis of microbiology manuscripts we review, roughly 30% of papers targeting Nature Microbiology or Cell Host and Microbe are extensions of previously published mechanistic work into a second organism or a clinical isolate collection without establishing any new mechanistic principle. Editors consistently screen for papers where the central finding would be described as "X mechanism, previously shown in organism A, also operates in organism B" without revealing any new biology. In practice, desk rejection tends to occur for papers where the novelty is essentially a demonstration that a known mechanism is conserved, without any new mechanistic insight into how or why the conservation matters.

Before submitting primary microbiology research, a pre-submission framing check identifies whether the mechanistic depth and biological relevance meet the editorial bar at Nature Microbiology, Cell Host and Microbe, or mBio.